Expedited DNA Testing Grant Program:
HB 847 creates the Expedited DNA Testing Grant Program within the Florida Department of Law Enforcement. The program is designed to provide annual grants to law enforcement agencies so they can pay for DNA testing of evidentiary items by private laboratories when needed. The bill defines “private laboratory” as a DNA lab accredited for at least five years under ISO/IEC 17025:2017 and FBI quality assurance standards.
The grants may be used in two main situations: when the necessary testing technology or technique is not available at a local or state laboratory, or when an agency determines that expedited testing would best advance an investigation. Each grant recipient must submit a report within one year describing the funding received, the number of cases tested, the type of testing used, the private lab used, the lab’s equipment, the test results, and the average turnaround time. The Department of Law Enforcement is authorized to adopt rules to administer the program and allocate funds, and the act takes effect July 1, 2025.
The bill adds a new section to the Florida Statutes, s. 943.328, and expands the Department of Law Enforcement’s responsibilities by creating a grant program tied to forensic DNA testing. It does not change criminal procedure directly, but it provides a funding mechanism that may speed evidence processing in criminal investigations by allowing agencies to outsource testing to qualified private laboratories. The bill also establishes reporting and rulemaking requirements that will shape how grant funds are distributed and tracked.
The available record shows no committee transcript or recorded votes, so there is no detailed public debate to assess. Based on the bill’s final enactment as Chapter No. 2025-141, the measure appears to have received sufficient support to pass and become law. The structure of the bill suggests a generally practical, law-enforcement-oriented approach focused on improving investigative efficiency and reducing DNA testing delays.
No specific points of contention are documented in the provided materials. Potential areas of policy concern, however, may include whether public funds should be used for private laboratory testing, how “expedited” need is determined by an agency, and whether the reporting requirements are sufficient to ensure accountability and transparency. Another possible issue is the reliance on private labs rather than expanding state or local laboratory capacity.